GA
TXG icon

GoalVest Advisory’s 10x Genomics TXG Stock Holding History

GoalVest Advisory’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$904 Buy
+10
New +$585 ﹤0.01% 689

Other funds holding TXG

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GoalVest Advisory's TXG Position: Q3 2026 in Review

GoalVest Advisory opened a new position in 10x Genomics (TXG) in Q3 2026: 10 shares worth $904. The stake represents ﹤0.01% of the portfolio and ranks #689 among its holdings.

10 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • GoalVest Advisory held 10 shares of 10x Genomics worth $904 as of Q3 2026.
  • 10x Genomics was a new GoalVest Advisory position in Q3 2026.
  • 10x Genomics made up ﹤0.01% of GoalVest Advisory's portfolio in Q3 2026, its #689 holding.
  • 10 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on GoalVest Advisory's 13F filing for Q3 2026, filed 2 Oct 2026.